{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:26:09Z","timestamp":1790727969656,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.taap.2021.115672","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T02:58:22Z","timestamp":1628823502000},"page":"115672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Inhibition of NLRP3 inflammasome activation in myeloid-derived suppressor cells by andrographolide sulfonate contributes to 5-FU sensitization in mice"],"prefix":"10.1016","volume":"428","author":[{"given":"Lingyan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peifen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiashu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2021.115672_bb0005","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","article-title":"Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Argiles","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.taap.2021.115672_bb0010","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2021.115672_bb0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nm.2999","article-title":"Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth","volume":"19","author":"Bruchard","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.taap.2021.115672_bb0020","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00018-017-2720-9","article-title":"Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma","volume":"75","author":"Chen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.taap.2021.115672_bb0025","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3390\/cells9061392","article-title":"The roles of cancer stem cells and therapy resistance in colorectal carcinoma","volume":"9","author":"Das","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.taap.2021.115672_bb0030","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/0008-5472.CAN-19-2080","article-title":"Tumor cell\u2013derived IL1\u03b2 promotes desmoplasia and immune suppression in pancreatic cancer","volume":"80","author":"Das","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2021.115672_bb0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00262-008-0523-4","article-title":"Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy","volume":"58","author":"Diaz-Montero","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.taap.2021.115672_bb0040","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(00)02034-1","article-title":"Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial","volume":"355","author":"Douillard","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2021.115672_bb0045","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41419-019-1723-x","article-title":"Docosahexaenoic acid inhibits both NLRP3 inflammasome assembly and JNK-mediated mature IL-1beta secretion in 5-fluorouracil-treated MDSC: implication in cancer treatment","volume":"10","author":"Dumont","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2021.115672_bb0050","first-page":"3324","article-title":"Tabu search algorithm analysis on effect of Xingnaojing injection in treatment of craniocerebral injury and complications in real world","volume":"45","author":"Geng","year":"2020","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.taap.2021.115672_bb0055","doi-asserted-by":"crossref","first-page":"iv22","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Glynne-Jones","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.taap.2021.115672_bb0060","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.intimp.2012.09.002","article-title":"Water-soluble andrographolide sulfonate exerts anti-sepsis action in mice through down-regulating p38 MAPK, STAT3 and NF-kappaB pathways","volume":"14","author":"Guo","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2021.115672_bb0065","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4161\/auto.28374","article-title":"Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer","volume":"10","author":"Guo","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.taap.2021.115672_bb0070","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.intimp.2017.11.042","article-title":"Andrographolide sulfonate reduces mortality in Enterovirus 71 infected mice by modulating immunity","volume":"55","author":"Li","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2021.115672_bb0075","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.3390\/molecules25215037","article-title":"Andrographolide and its 14-aryloxy analogues inhibit zika and dengue virus infection","volume":"25","author":"Li","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.taap.2021.115672_bb0080","first-page":"3518","article-title":"Analysis of clinical application characteristics of Xiyanping injection in 194 873 cases in real world","volume":"45","author":"Li","year":"2020","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.taap.2021.115672_bb0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.intimp.2014.03.015","article-title":"Andrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1\/Th17 response","volume":"20","author":"Liu","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2021.115672_bb0090","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.intimp.2015.04.025","article-title":"Gastroprotective effect of andrographolide sodium bisulfite against indomethacin-induced gastric ulceration in rats","volume":"26","author":"Liu","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2021.115672_bb0095","doi-asserted-by":"crossref","first-page":"106206","DOI":"10.1016\/j.intimp.2020.106206","article-title":"Andrographolide potentiates PD-1 blockade immunotherapy by inhibiting COX2-mediated PGE2 release","volume":"81","author":"Liu","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2021.115672_bb0100","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.taap.2021.115672_bb0105","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","article-title":"Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes","volume":"156","author":"Lu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.taap.2021.115672_bb0110","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.canlet.2020.10.024","article-title":"NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma","volume":"497","author":"Lu","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.taap.2021.115672_bb0115","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1600-065X.2008.00602.x","article-title":"Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells","volume":"222","author":"Marigo","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.taap.2021.115672_bb0120","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41419-019-1491-7","article-title":"HSP70 is a negative regulator of NLRP3 inflammasome activation","volume":"10","author":"Martine","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2021.115672_bb0125","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ni.2550","article-title":"Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome","volume":"14","author":"Misawa","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.taap.2021.115672_bb0130","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","article-title":"Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity","volume":"111","author":"Movahedi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.taap.2021.115672_bb0135","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4049\/jimmunol.1701019","article-title":"Myeloid-derived suppressor cells: immune-suppressive cells that impair antitumor immunity and are sculpted by their environment","volume":"200","author":"Ostrand-Rosenberg","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2021.115672_bb0140","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.taap.2021.115672_bb0145","doi-asserted-by":"crossref","first-page":"80262","DOI":"10.18632\/oncotarget.12918","article-title":"Andrographolide ameliorates OVA-induced lung injury in mice by suppressing ROS-mediated NF-\u03baB signaling and NLRP3 inflammasome activation","volume":"7","author":"Peng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2021.115672_bb0150","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000478","article-title":"Heat shock and HSP70 regulate 5-FU-mediated caspase-1 activation in myeloid-derived suppressor cells and tumor growth in mice","volume":"8","author":"Pilot","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.taap.2021.115672_bb0155","doi-asserted-by":"crossref","first-page":"111285","DOI":"10.1016\/j.biopha.2021.111285","article-title":"5-fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: implication of DNA repair inhibition","volume":"137","author":"Sethy","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2021.115672_bb0160","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.taap.2021.115672_bb0165","doi-asserted-by":"crossref","first-page":"4510591","DOI":"10.1155\/2019\/4510591","article-title":"Cost-effectiveness analysis of Xiyanping injection (andrographolide sulfonate) for treatment of adult community acquired pneumonia: a retrospective, propensity score-matched cohort study","volume":"2019","author":"Shi","year":"2019","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.taap.2021.115672_bb0170","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.taap.2021.115672_bb0175","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2147\/DDDT.S140354","article-title":"Andrographolide enhanced 5-fluorouracil-induced antitumor effect in colorectal cancer via inhibition of c-MET pathway","volume":"11","author":"Su","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.taap.2021.115672_bb0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bcp.2017.03.024","article-title":"Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action","volume":"139","author":"Tan","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2021.115672_bb0185","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2000915118","article-title":"Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion","volume":"118","author":"Tengesdal","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2021.115672_bb0190","doi-asserted-by":"crossref","first-page":"10161","DOI":"10.1158\/0008-5472.CAN-10-1921","article-title":"The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells","volume":"70","author":"van Deventer","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2021.115672_bb0195","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1158\/0008-5472.CAN-09-3690","article-title":"5-fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity","volume":"70","author":"Vincent","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2021.115672_bb0200","doi-asserted-by":"crossref","first-page":"107447","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2021.115672_bb0205","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bcp.2016.09.024","article-title":"Andrographolide reversed 5-FU resistance in human colorectal cancer by elevating BAX expression","volume":"121","author":"Wang","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2021.115672_bb0210","first-page":"5282","article-title":"Expert consensus statement on Xiyanping injection for respiratory system infectious diseases in clinical practice (adults)","volume":"44","author":"Wang","year":"2019","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.taap.2021.115672_bb0215","article-title":"DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS\u2013STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis","author":"Wang","year":"2021","journal-title":"Acta Pharmaceut. Sin. B"},{"key":"10.1016\/j.taap.2021.115672_bb0220","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12935-020-01290-z","article-title":"Apatinib suppresses tumor progression and enhances cisplatin sensitivity in esophageal cancer via the Akt\/beta-catenin pathway","volume":"20","author":"Wei","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.taap.2021.115672_bb0225","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s13402-020-00529-1","article-title":"Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update","volume":"43","author":"Xie","year":"2020","journal-title":"Cell Oncol. (Dordr.)"},{"key":"10.1016\/j.taap.2021.115672_bb0230","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0254-6272(17)30077-8","article-title":"Xiyanping injection therapy for children with mild hand foot and mouth disease: a randomized controlled trial","volume":"37","author":"Zhang","year":"2017","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.taap.2021.115672_bb0235","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.3892\/ol.2017.6669","article-title":"Andrographolide suppresses proliferation of human colon cancer SW620 cells through the TLR4\/NF-\u03baB\/MMP-9 signaling pathway","volume":"14","author":"Zhang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.taap.2021.115672_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.7141","article-title":"Efficacy and safety of Xiyanping injection in the treatment of COVID-19: a multicenter, prospective, open-label and randomized controlled trial","author":"Zhang","year":"2021","journal-title":"Phytother. Res."},{"key":"10.1016\/j.taap.2021.115672_bb0245","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4161\/auto.18721","article-title":"Andrographolide sensitizes cisplatin-induced apoptosis via suppression of autophagosome-lysosome fusion in human cancer cells","volume":"8","author":"Zhou","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.taap.2021.115672_bb0250","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/gutjnl-2017-314032","article-title":"Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy","volume":"67","author":"Zhou","year":"2018","journal-title":"Gut"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21002763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21002763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:55:46Z","timestamp":1758574546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X21002763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":50,"alternative-id":["S0041008X21002763"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2021.115672","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of NLRP3 inflammasome activation in myeloid-derived suppressor cells by andrographolide sulfonate contributes to 5-FU sensitization in mice","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2021.115672","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115672"}}